Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Chaoying Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0484-9522; OpenAlex author ID A5026782331. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. Prognostic and Diagnostic Value of Serum Bile Acid Profiles in Pancreatic Cancer: a Retrospective Multicenter Cohort Study. Co-author DOI 10.1007/s12029-025-01283-z↗
  2. NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature. Co-author DOI 10.3389/fphar.2022.1025921↗
  3. Profiles and clinical significance of immune cell infiltration in pancreatic adenocarcinoma Last author DOI 10.1101/2020.03.30.017327↗
  4. The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001364↗
  5. High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-012-0617-7↗
  6. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Co-author DOI 10.1038/labinvest.2013.69↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junying Xu · 4 shared papers, 2013–2022 · strength 0.34
  2. Henan Qin · 1 shared paper, 2026 · strength 0.32
  3. Peiyuan Yin · 1 shared paper, 2026 · strength 0.32
  4. Junli Ding · 3 shared papers, 2013–2022 · strength 0.29
  5. Rui Xu · 2 shared papers, 2020–2022 · strength 0.28
  6. Jie Mei · 2 shared papers, 2020–2022 · strength 0.28
  7. Zhiyang Jiang · 1 shared paper, 2022 · strength 0.15
  8. Lei Wang · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.